logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

The Bitterest Pills The Troubling Story Of Antipsychotic Drugs Joanna Moncrieff

  • SKU: BELL-4704328
The Bitterest Pills The Troubling Story Of Antipsychotic Drugs Joanna Moncrieff
$ 31.00 $ 45.00 (-31%)

4.1

70 reviews

The Bitterest Pills The Troubling Story Of Antipsychotic Drugs Joanna Moncrieff instant download after payment.

Publisher: Palgrave Macmillan
File Extension: PDF
File size: 1.15 MB
Pages: 296
Author: Joanna Moncrieff
ISBN: 9781137277428, 1137277424
Language: English
Year: 2013

Product desciption

The Bitterest Pills The Troubling Story Of Antipsychotic Drugs Joanna Moncrieff by Joanna Moncrieff 9781137277428, 1137277424 instant download after payment.

Antipsychotic (neuroleptic) drugs have become some of the biggest blockbusters of the early 21st century, increasingly prescribed not just to people with 'schizophrenia' or other severe forms of mental disturbance but for a range of more common psychological complaints. This book challenges the accepted account that portrays antipsychotics as specific treatments that target an underlying brain disease and explores early views that suggested, in contrast, that antipsychotics achieve their effects by inducing a state of neurological suppression. Professional enthusiasm for antipsychotics eclipsed this understanding, exaggerated the benefits of antipsychotics and minimized or ignored evidence of their toxic effects. The pharmaceutical industry has been involved in expanding the use of antipsychotics into territory where it is likely that their dangers far outweigh their advantages.

Related Products